Report #2832462

Received Mar 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 61 yrs
State: SC
Recovered: Recovered
Vaccinated: Mar 19, 2025
Onset: Mar 19, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	944917	IM / RA
PNC20	PNEUMO (PREVNAR20)	PFIZER\WYETH	1	LK6650	IM / LA

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

Heplisav Vaccine: no issues, Prevnar vaccine: patient has already received one dose on 10/13/2023. We were unaware, which is why he received one outside of dosing interval/recommendation on 03/19/25. Patient did not have any adverse events with this second dose of Prevnar.

Current illness

none

Medical history

heart disease, diabetes, arthritis

Other medications

amlodipine, ozempic, ciclopirox shampoo, fluocinonide otic drops, meloxicam, valsartan-hctz, bupropion

Allergies

no known allergies

Lab data

None